Those individuals with prescription insurance were significantly more likely to use medication for osteoporosis than individuals without prescription insurance (OR = 1.56; 95% CI, 1.20–2.00).

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Medication use was dichotomized as present or absent for each respondent in each calendar year if there was any record of a prescription purchase for the treatment of osteoporosis. Specific ...

Should you take a drug to treat osteoporosis or osteopenia ... of consumer-fraud claims regarding the marketing of the prescription drug Neurontin (gabapentin). If you think you have experienced ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

A singer has said that she was diagnosed with osteoporosis after she used Ozempic, a drug not licensed for weight loss ...

The Food and Drug Administration (FDA) recently approved romosozumab (Evenity), a new drug for osteoporosis. Unlike osteoporosis medicines called bisphosphonates, romosozumab doesn’t just stop bone ...

An everyday medication taken by over 3 million people in the UK for hypothyroidism could be increasing the risk of osteoporosis, new research suggests. Levothyroxine, the standard treatment for ...

Taking the osteoporosis drug alendronate (Fosamax ... and in patients who filled prescriptions for proton pump inhibitors; both of those have been found to be risk factors in previous studies.

Osteoporosis is a disabling skeletal disorder that is characterized by decreased bone strength, predisposing patients to increased risk of bone fracture. Peak bone mass (maximum bone strength and ...

Two biosimilars of Eli Lilly’s blockbuster osteoporosis treatment Forsteo ... Forsteo (teriparatide) – a bone-building parathyroid hormone drug sold as Forteo in the US – has been ...

osteoporosis, and substance use disorder, CMS said. Since April 1, 2023, people with Medicare have seen savings on over 120 drugs thanks to Inflation Reduction Act’s Medicare Prescription Drug ...